GB202103122D0
|
|
Treatment
|
GB202100821D0
|
|
Method for treating rheumatoid arthritis
|
GB202020423D0
|
|
Composition comprising calcium phosphate and a bioactive glass comprising fluorine
|
GB202019594D0
|
|
Sustained release formulations of crystalline drugs
|
GB202019417D0
|
|
A double non-parallel staggered grating backward wave oscillator for ultra-broadband high-power thz generation
|
GB202017502D0
|
|
Image processing of intravenous ultrasound images
|
GB202014743D0
|
|
Photocurable silicone compositions and methods
|
GB202014594D0
|
|
Locomotion system for a medical device
|
GB202013036D0
|
|
Monocrystalline thin films
|
GB202012804D0
|
|
Agrin polypeptide and uses thereof
|
GB202011523D0
|
|
Neuromodulation for the treatment of critical illness
|
GB202011196D0
|
|
Solvent annealing
|
GB202010922D0
|
|
Method
|
WO2020208358A1
|
|
Radiation detector
|
GB202003871D0
|
|
Computerised methodology for automated detection of the end-diastolic intravascular ultrasound images
|
WO2020144475A1
|
|
Process for producing a poly(vinylidene fluoride) dielectric material for capacitor with rich beta cristalline phase
|
GB201915054D0
|
|
Diagnosis
|
GB201914079D0
|
|
Method of predicting requirement for biologic therapy
|
GB201913383D0
|
|
Methods for predicting patient response to DMARDs
|
GB201912010D0
|
|
Signal processing device
|